Patient-Reported Outcomes of COVID-19 Vaccine Breakthrough Infection-Associated Changes in Glucose Control in Subjects With Type 1 Diabetes (PRO-VACS 2 Study)

Diabetes Care. 2023 Jan 1;46(1):e8-e9. doi: 10.2337/dc22-0868.
No abstract available

Publication types

  • Letter

MeSH terms

  • Blood Glucose
  • Breakthrough Infections
  • COVID-19 Vaccines / therapeutic use
  • COVID-19* / prevention & control
  • Diabetes Mellitus, Type 1* / complications
  • Humans
  • Patient Reported Outcome Measures

Substances

  • COVID-19 Vaccines
  • Blood Glucose

Supplementary concepts

  • COVID-19 breakthrough infections